中国糖尿病防治指南

Size: px

Start display at page:

Download "中国糖尿病防治指南"

菘解蚁尤
9 years ago
Views:

2 ~2000 << >><<>> <<>> mgdl(7.0mmoll)110mg/dl(6.1mmol/l)126mg/dl(7.0mmol/l <<>> <<>> 1

5 2

7 3

10 4

12 5

13 6

15 7

17 8 2

18 9

20 10

22 10-1

23 * 10-2 * HbA1c LDL-C HDL-C

24 46 1 HbA1c 1 / * 11

25 mmol/l > >10.0 HbA1c% < >7.5 mmhg <130/80 >130/80 140/90 <140/90 BMIkg/m 2 <25 <27 27 <24 <26 26 TCmmol/L < HDL-Cmmol/L > <0.9 TGmmol/L < >2.2 LDL-Cmmol/L* < >3.3 *

26 4 20%30% 1/3 100mg/dl2 6mmol/L 10%<300 mg/d 100mg/dl26mmol/L<200 mg/d 5 55%65% 6 15% g/kg 0.8g/kg g/d mg/d >15mmol/L >35 2 >10 1 >15

27 %* < > *= mmol/L(>360mg/dl) 2 / 10%15%

28 2 3 HbA1C A1C HbA1C HbA1C HbA1C DCCT UKPDS HbA1C HbA1C HbA1C 2 HbA1C 3 1 HbA1C mg/dl mmol/L(300mg/dl)

29 / () /

30 2 UKPDS %50% U/kg U/kg pm 1 RI IA +NPH RI IA RI IA NPH 2 RI IA +NPH RI IA +NPH 3 * RI IA + RI IA RI IA Glargine PZI RI=IA =NPH=PZI= *RI IA Glargine PZI

31 <130/80mmHgACEI mg/dl mg/dl mg/dl mg/dlhba1c >105 mg/dl 2 >140 mg/dl

32 [3mg/dl(2.65mmol/L),<50ml/min] / %40%

33 1 C >60 > IGT 65 10%20%

34 13

37 14

42 14-5

44 2

45 PTCA CT,MRI L- rt-pa

46 % 3: 4 99% 1 60% NPDR NPDR NPDR NPDR PDR 1

47 NPDR PDR % 1 500m 500m 2 50% 4 5 NPDR PDR NPDR PDR 6 Mongensen

48 GFRGFR 2 UAER<20g/min <30mg/d GFR GBM 3 UAER 20200g/min 30300mg/d GFR GBM 4 >3.5g/d GFR UAER 20200g/min 30300mg/d GBM Kimmelstiel-Wilson 1 <6.1mmol/L(110mg/dl) <8.0mmol/L(144mg/dl)<6.5% 2ACEI II ARB ACEI ARB %50% 4>265mol/L(3mg/dl) 3

49 <1.0g/d <130/80mmHg>1.0g/d <125/75mmHg 4 TC<4.5mmol/L,LDL-C<2.6mmol/L,HDL-C>1.1mmol/L,TG<1.5mmol/L. TC LDL-C kD kD ml/d 3g/d 2 1 ACEI ARB 0.6g/kg kJ/kg(30 35kcal/kg) 2 3 D3 4 : >530 mol/l(6mg/dl),<1520ml/min % 2 3

50 4 5 2% 10 60%90% 30%40% >90 / QT 2 3 4

51 5 6: 1 1 EC 2 B1B12 B12 3 E IU/d 2 1/ mg/d / %22% % 5

52 %0.05% mmol/L 2 8.8mmol/L

53 2 Charcot 0.1%0.4% /3 73% % 2 () : 31.5%27.4%(21.8%)(10.2%) (9.1%) X. Charcot X 3,,, 5%10% 1% %, 7.3% 80%

54 Wagner Wagner cellulitis g Charcot X Biothesiometer TcPO

55 % 3 4 NIH 1993 impotence (erectile dysfunction,ed)

56 ED ED ED ED ED 1 100% ED 2 ED 3 ED 4 ED 5 ED ED II EF EDII EF-5 ED 98% 88%II EF-5

57 1 ED 2 ED 3 i. sidenafil-5pde5 ii. trazodoneapomorphine 4 E1PGE1 PGE1 5 6 ED 35 1%3% % 88% 4.4%18.2%, 19.3%24.1%,,, 66.5% 99.2% X X 75% 12 CT

58 B6 X 15 30%50% / / /

59 /23/ self-rating depression scale,sds 2 (self-rating anxiety scale,sas) /5

60 / TGF- 1 ICAM-1 1

61 1 2 MRFIT nicotine replacement therapy NRT 1 40%60% 4mg 2mg NHANESI

62 <10% MODY 0.5 3

<4D6963726F736F667420576F7264202D20B4BAD3EABCC6BBAEA1AAA1AAA1B6D6D0B9FAB8DFD1AAD1B9BBBCD5DFBDCCD3FDD6B8C4CFA1B7CDC6B9E3CFEEC4BFC5E0D1B5BDCCB2C42E646F63>

<4D6963726F736F667420576F7264202D20B4BAD3EABCC6BBAEA1AAA1AAA1B6D6D0B9FAB8DFD1AAD1B9BBBCD5DFBDCCD3FDD6B8C4CFA1B7CDC6B9E3CFEEC4BFC5E0D1B5BDCCB2C42E646F63> 中国高血压患者教育指南中国高血压患者教育指南编撰委员会顾问 : 刘力生主任委员 : 副主任委员 : 吴兆苏霍勇王文赵连友朱鼎良编撰委员会 : 陈鲁原陈伟伟鄂啟顺郭冀珍孔灵芝李南方刘蔚洪昭光黄峻隋辉孙宁玲唐新华王文王增武